China National Medicines Corporation Ltd. (SHA:600511)

Market Cap	20.12B -9.2%
Revenue (ttm)	53.31B +4.1%
Net Income	2.01B +0.6%
EPS	2.67 +0.6%
Shares Out	754.50M
PE Ratio	10.00
Forward PE	9.59
Dividend	0.80 (2.99%)
Ex-Dividend Date	Jun 18, 2025

Volume	3,031,895
Open	26.75
Previous Close	26.80
Day's Range	26.61 - 26.96
52-Week Range	26.42 - 31.55
Beta	0.21
Analysts	Strong Buy
Price Target	36.43 (+36.6%)
Earnings Date	Aug 24, 2026

About SHA:600511

China National Medicines Corporation Ltd., together with its subsidiaries, engages in pharmaceutical equipment circulation in China. The company also manufactures and sells new drugs; sells Chinese patent medicines drug sales and western medicines, and medical equipment; and offers dental drug and equipment, warehousing, logistics and import and export agency services. It also serves hospitals, retail pharmacies, and medical institutions. The company was founded in 1999 and is based in Beijing, China. China National Medicines Corporation Ltd. o...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1999
• Employees: 3,024
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600511

Financial Performance

In 2025, SHA:600511's revenue was 52.47 billion, an increase of 3.70% compared to the previous year's 50.60 billion. Earnings were 2.00 billion, a decrease of -0.18%.